Current Cancer Therapy Reviews
Title:The Pure Guy – The Scientist
Volume: 15 Issue: 1
Author(s): Kurt S. Zaenker
Affiliation:
Export Options
About this article
Cite this article as:
Zaenker S. Kurt , The Pure Guy – The Scientist, Current Cancer Therapy Reviews 2019; 15 (1) . https://dx.doi.org/10.2174/157339471501190201103609
DOI https://dx.doi.org/10.2174/157339471501190201103609 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Quantitative Proteomics Profiling of RKO and HT29 Cell Lines by iTRAQ Coupled LC-MS/MS
Current Proteomics What We Learnt from Randomized Clinical Trials and Cohort Studies of Antioxidant Vitamin? : Focus on Vitamin E and Cardiovascular Disease
Current Pharmaceutical Biotechnology Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
Current Drug Targets Purification and Characterization of a Lectin of the Swartzieae Legume Taxa
Protein & Peptide Letters In Vitro and In Vivo Evaluation of Guar Gum-Based Matrix Tablets of Rofecoxib for Colonic Drug Delivery
Current Drug Delivery Realising the Potential of Adaptive Development of Medicines
Reviews on Recent Clinical Trials Peptides to Target Tumor Vasculature and Lymphatics for Improved Anti-Angiogenesis Therapy
Current Cancer Drug Targets Progress in Nutritional and Health Profile of Milk and Dairy Products: A Novel Drug Target
Endocrine, Metabolic & Immune Disorders - Drug Targets Vaccines for Patients with COPD
Recent Patents on Inflammation & Allergy Drug Discovery Gene Therapy: Optimising DNA Delivery to the Nucleus
Current Drug Targets Novel Agents, Combinations and Sequences for the Treatment of Advanced Renal Cell Carcinoma: When is the Revolution Coming?
Current Cancer Drug Targets Disordered Interactome of Human Papillomavirus
Current Pharmaceutical Design Pro- and Anti-Inflammatory Cytokine Expression Levels in Macrophages; An Approach to Develop Indazolpyridin-methanones as Novel Inflammation Medication
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Comprehensive Analysis Reveals GPRIN1 is a Potential Biomarker for Non-sm all Cell Lung Cancer
Current Bioinformatics Silver Nanoparticles with High Loading Capacity of Amphotericin B: Characterization, Bactericidal and Antifungal Effects
Current Drug Delivery Patent Selections
Recent Patents on Biotechnology Radiotherapy Planning and Molecular Imaging in Lung Cancer
Current Radiopharmaceuticals Carbonic Anhydrase Inhibitors Developed Through ‘Click Tailing’
Current Pharmaceutical Design Overview of the Formulations and Analogs in the Taxanes' Story
Current Medicinal Chemistry Network Pharmacology: Reigning in Drug Attrition?
Current Drug Discovery Technologies